Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Biopharmaceutical Buffers Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4305278
  • |
  • 13 April, 2021
  • |
  • Global
  • |
  • 128 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Biopharmaceutical Buffers Market Status and Forecast (2016-2027)
      • 1.3.2 Global Biopharmaceutical Buffers Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Biopharmaceutical Buffers Supply by Company

    • 2.1 Global Biopharmaceutical Buffers Sales Volume by Company
    • 2.2 Global Biopharmaceutical Buffers Sales Value by Company
    • 2.3 Global Biopharmaceutical Buffers Price by Company
    • 2.4 Biopharmaceutical Buffers Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Biopharmaceutical Buffers Market Status by Category

    • 3.1 Biopharmaceutical Buffers Category Introduction
      • 3.1.1 Phosphates Buffer
      • 3.1.2 Acetates Buffer
      • 3.1.3 TRIS Buffer
      • 3.1.4 Others
    • 3.2 Global Biopharmaceutical Buffers Market by Category
      • 3.2.1 Global Biopharmaceutical Buffers Sales Volume by Category (2016-2021)
      • 3.2.2 Global Biopharmaceutical Buffers Sales Value by Category (2016-2021)
      • 3.2.3 Global Biopharmaceutical Buffers Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Biopharmaceutical Buffers Market Status by End User/Segment

    • 4.1 Biopharmaceutical Buffers Segment by End User/Segment
      • 4.1.1 Research Institution
      • 4.1.2 Pharmaceutical Industry
      • 4.1.3 Others
    • 4.2 Global Biopharmaceutical Buffers Market by End User/Segment
      • 4.2.1 Global Biopharmaceutical Buffers Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Biopharmaceutical Buffers Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Biopharmaceutical Buffers Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Biopharmaceutical Buffers Market Status by Region

    • 5.1 Global Biopharmaceutical Buffers Market by Region
      • 5.1.1 Global Biopharmaceutical Buffers Sales Volume by Region
      • 5.1.2 Global Biopharmaceutical Buffers Sales Value by Region
    • 5.2 North America Biopharmaceutical Buffers Market Status
    • 5.3 Europe Biopharmaceutical Buffers Market Status
    • 5.4 Asia Pacific Biopharmaceutical Buffers Market Status
    • 5.5 Central & South America Biopharmaceutical Buffers Market Status
    • 5.6 Middle East & Africa Biopharmaceutical Buffers Market Status

    6 North America Biopharmaceutical Buffers Market Status

    • 6.1 North America Biopharmaceutical Buffers Market by Country
      • 6.1.1 North America Biopharmaceutical Buffers Sales Volume by Country (2016-2021)
      • 6.1.2 North America Biopharmaceutical Buffers Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Biopharmaceutical Buffers Market Status

    • 7.1 Europe Biopharmaceutical Buffers Market by Country
      • 7.1.1 Europe Biopharmaceutical Buffers Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Biopharmaceutical Buffers Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Biopharmaceutical Buffers Market Status

    • 8.1 Asia Pacific Biopharmaceutical Buffers Market by Country
      • 8.1.1 Asia Pacific Biopharmaceutical Buffers Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Biopharmaceutical Buffers Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Biopharmaceutical Buffers Market Status

    • 9.1 Central & South America Biopharmaceutical Buffers Market by Country
      • 9.1.1 Central & South America Biopharmaceutical Buffers Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Biopharmaceutical Buffers Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Biopharmaceutical Buffers Market Status

    • 10.1 Middle East & Africa Biopharmaceutical Buffers Market by Country
      • 10.1.1 Middle East & Africa Biopharmaceutical Buffers Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Biopharmaceutical Buffers Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Biopharmaceutical Buffers Distributors
    • 11.3 Biopharmaceutical Buffers Buyers

    12 Global Biopharmaceutical Buffers Market Forecast by Category and by End User/Segment

    • 12.1 Global Biopharmaceutical Buffers Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Biopharmaceutical Buffers Forecast by Category
      • 12.2.1 Global Biopharmaceutical Buffers Sales Volume Forecast by Category
      • 12.2.2 Global Biopharmaceutical Buffers Sales Value Forecast by Category
      • 12.2.3 Global Biopharmaceutical Buffers Price Forecast by Category
    • 12.3 Global Biopharmaceutical Buffers Forecast by End User/Segment
      • 12.3.1 Global Biopharmaceutical Buffers Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Biopharmaceutical Buffers Sales Value Forecast by End User/Segment
      • 12.3.3 Global Biopharmaceutical Buffers Price Forecast by End User/Segment

    13 Global Biopharmaceutical Buffers Market Forecast by Region/Country

    • 13.1 Global Biopharmaceutical Buffers Market Forecast by Region (2022-2027)
      • 13.1.1 Global Biopharmaceutical Buffers Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Biopharmaceutical Buffers Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Avantor
      • 14.1.1 Company Information
      • 14.1.2 Biopharmaceutical Buffers Product Introduction
      • 14.1.3 Avantor Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Alfa Aesar (Thermo Fisher)
      • 14.2.1 Company Information
      • 14.2.2 Biopharmaceutical Buffers Product Introduction
      • 14.2.3 Alfa Aesar (Thermo Fisher) Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Bio-Rad
      • 14.3.1 Company Information
      • 14.3.2 Biopharmaceutical Buffers Product Introduction
      • 14.3.3 Bio-Rad Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Promega Corporation
      • 14.4.1 Company Information
      • 14.4.2 Biopharmaceutical Buffers Product Introduction
      • 14.4.3 Promega Corporation Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 BD
      • 14.5.1 Company Information
      • 14.5.2 Biopharmaceutical Buffers Product Introduction
      • 14.5.3 BD Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 GE Healthcare
      • 14.6.1 Company Information
      • 14.6.2 Biopharmaceutical Buffers Product Introduction
      • 14.6.3 GE Healthcare Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 XZL BIO-TECHNOLOGY
      • 14.7.1 Company Information
      • 14.7.2 Biopharmaceutical Buffers Product Introduction
      • 14.7.3 XZL BIO-TECHNOLOGY Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Merck
      • 14.8.1 Company Information
      • 14.8.2 Biopharmaceutical Buffers Product Introduction
      • 14.8.3 Merck Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Hamilton Company
      • 14.9.1 Company Information
      • 14.9.2 Biopharmaceutical Buffers Product Introduction
      • 14.9.3 Hamilton Company Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 SRL
      • 14.10.1 Company Information
      • 14.10.2 Biopharmaceutical Buffers Product Introduction
      • 14.10.3 SRL Biopharmaceutical Buffers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Lonza

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Biopharmaceutical Buffers market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Biopharmaceutical Buffers market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Phosphates Buffer
    Acetates Buffer
    TRIS Buffer
    Others

    Segmented by End User/Segment
    Research Institution
    Pharmaceutical Industry
    Others

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Avantor
    Alfa Aesar (Thermo Fisher)
    Bio-Rad
    Promega Corporation
    BD
    GE Healthcare
    XZL BIO-TECHNOLOGY
    Merck
    Hamilton Company
    SRL
    Lonza


    Summary:
    Get latest Market Research Reports on Biopharmaceutical Buffers. Industry analysis & Market Report on Biopharmaceutical Buffers is a syndicated market report, published as Dynamics in Post-pandemic Global Biopharmaceutical Buffers Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Biopharmaceutical Buffers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,980.00
    $4,470.00
    $5,960.00
    2,112.82
    3,169.23
    4,225.64
    2,455.52
    3,683.28
    4,911.04
    326,012.00
    489,018.00
    652,024.00
    218,612.80
    327,919.20
    437,225.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report